POLYPEPTIDE MONOMERS AND DIMERS CONTAINING MUTATED ILT

摘要

The present invention provides monomeric and dimeric polypeptide fusions comprising mutated human ILT molecules and immunoglobulin Fc segments. Such compostions are useful, either alone or associated with a therapeutic agent, for targeting cells expressing Class I pMHC molecules.